4-Butylresorcinol

INCI: 4-Butylresorcinol 

Category: Depigmenting Agent / High Potency Brightening Active 

Used in: Brightening serums, dark spot correctors, targeted hyperpigmentation treatments 

Typical Usage Level (Topical): 0.1–0.3%

What This Ingredient Does

4-Butylresorcinol is a resorcinol derivative and one of the most potent non-prescription depigmenting actives available. It inhibits melanin synthesis at multiple points in the pathway simultaneously: it inhibits both tyrosinase and TRP-1 (tyrosinase-related protein-1), a secondary enzyme involved in eumelanin production. This multi-step blockade makes it significantly more effective than single-target inhibitors such as arbutin or kojic acid at comparable concentrations. Studies have also demonstrated it reduces the expression of melanogenic proteins rather than only blocking enzyme activity  addressing pigmentation at both the protein and enzymatic level. At low concentrations (0.1–0.3%), it delivers measurable clinical results with a manageable tolerability profile, though some users experience mild irritation during initial use.

Can be combined with Tranexamic Acid and Niacinamide for coverage across synthesis, signalling, and transfer stages of the pigmentation pathway.

Key Benefits

• Inhibits tyrosinase and TRP-1 simultaneously dual-enzyme blockade for stronger depigmentation

• More potent than arbutin, kojic acid, and most botanical brighteners at equivalent use levels

• Reduces melanogenic protein expression beyond direct enzyme inhibition

• Clinically demonstrated reduction in dark spot intensity and melasma severity

• Effective at low concentrations, reducing formulation-level irritation risk

Who It's Best For

• Those with stubborn hyperpigmentation, melasma, or deep post-inflammatory marks that have not responded to gentler brighteners

• Adults 25+ targeting persistent dark spots or sun-induced pigmentation

• Not first-line for sensitive or reactive skin introduce slowly with patch testing

• Fitzpatrick types IV–VI should use with caution and under dermatologist guidance; rebound pigmentation possible if SPF is not maintained

Clinical Note by Dr. Su

4-Butylresorcinol is the most clinically credible non-prescription brightener for stubborn pigmentation. The dual-enzyme inhibition is what sets it apart arbutin blocks tyrosinase, but this blocks two enzymes and also reduces protein expression. That said, potency comes with responsibility: it must be paired with consistent SPF use, and darker skin tones should introduce it gradually. This is not a casual-use ingredient.

References

• Kolbe L, et al. (2013). 4-n-Butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Journal of the European Academy of Dermatology and Venereology. PMID: 23039047

• Hamed SH, et al. (2010). Comparative efficacy and safety of deoxyarbutin, kojic acid, niacinamide, and ellagic acid as skin lightening agents. International Journal of Dermatology. PMID: 20546087